Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After Major Surgery for Inflammatory Bowel Disease - A Pragmatic Clinical Trial

NCT05104229 is registered in ClinicalTrials.gov with Stefan Holubar MD MS FACS, FASCRS as lead sponsor.

NCT NCT05104229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05104229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After Major Surgery for Inflammatory Bowel Disease - A Pragmatic Clinical Trial
Lead sponsor
Stefan Holubar MD MS FACS, FASCRS
Phase
Phase 3
Overall status
Withdrawn
Start date
June 1, 2024
Completion date
January 1, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis, venous thromboembolism